Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Dice Therapeutics Inc
(NQ:
DICE
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Aug 8, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Dice Therapeutics Inc
< Previous
1
2
3
4
Next >
Why Is Dice Therapeutics (DICE) Stock Up 38% Today?
June 20, 2023
Dice Therapeutics (DICE) stock is surging higher on Tuesday after Eli Lilly (LLY) announced plans to acquire the biopharmaceutical company.
Via
InvestorPlace
Dice Therapeutics Stock Catapults To Record High On $2.4 Billion Eli Lilly Buyout
June 20, 2023
Eli Lilly is adding a new suite of experimental immunology treatments to its pipeline.
Via
Investor's Business Daily
Why DICE Therapeutics Stock Is Soaring Tuesday
June 20, 2023
DICE TherapeuticsInc (NASDAQ: DICE) shares are trading higher Tuesday afterEli Lilly And Co (NYSE: LLY) agreed to acquire ...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
June 20, 2023
Gainers
Via
Benzinga
2 Biopharma Stocks Making Big Moves Tuesday
June 20, 2023
Markets looked poised for a pause, but these stocks didn't stand still.
Via
The Motley Fool
DICE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of DICE Therapeutics, Inc. Is Fair to Shareholders
June 20, 2023
From
Halper Sadeh LLC
Via
Business Wire
Recap: DICE Therapeutics Q1 Earnings
May 11, 2023
Via
Benzinga
Over $40M Bet On 89bio? Check Out These 3 Stocks Insiders Are Buying
March 31, 2023
Although US stocks closed higher on Thursday, there were a few notable insider trades.
Via
Benzinga
Where DICE Therapeutics Stands With Analysts
November 15, 2022
Via
Benzinga
DICE Therapeutics to Host R&D Investor Event on Tuesday, June 20, 2023
June 13, 2023
From
DICE Therapeutics, Inc.
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For May 24, 2023
May 24, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 22, 2023
May 22, 2023
Via
Benzinga
DICE Therapeutics Reports First Quarter 2023 Financial Results and Recent Highlights
May 11, 2023
From
DICE Therapeutics, Inc.
Via
GlobeNewswire
DICE Therapeutics to Participate in the Bank of America Securities 2023 Healthcare Conference
May 03, 2023
From
DICE Therapeutics, Inc.
Via
GlobeNewswire
DICE Therapeutics to Participate in the H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference
March 23, 2023
From
DICE Therapeutics, Inc.
Via
GlobeNewswire
DICE Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Highlights
March 15, 2023
From
DICE Therapeutics, Inc.
Via
GlobeNewswire
DICE Therapeutics Announces Late-Breaking Presentation at the 2023 American Academy of Dermatology (AAD) Annual Meeting
March 01, 2023
From
DICE Therapeutics, Inc.
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2023
March 01, 2023
Via
Benzinga
DICE Therapeutics to Participate at Upcoming Investor Conferences
February 08, 2023
From
DICE Therapeutics, Inc.
Via
GlobeNewswire
DICE Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 04, 2023
From
DICE Therapeutics, Inc.
Via
GlobeNewswire
These 3 Stocks Are Crushing the Market. Wall Street Thinks They Can Soar at Least 78% Higher.
November 18, 2022
The good times could keep on rolling for these big winners.
Via
The Motley Fool
Blue Star (NASDAQ: BSFC) Insiders Are Buying Stock
November 11, 2022
One indicator of where a company’s stock might be going in the future can be understood by what insiders may be thinking of the Company’s current stock price and near-term future outlook. Insiders are...
Via
Benzinga
DICE Therapeutics Reports Third Quarter 2022 Financial Results and Recent Highlights
November 09, 2022
From
DICE Therapeutics, Inc.
Via
GlobeNewswire
DICE Therapeutics to Present at Upcoming Investor Conferences
November 03, 2022
From
DICE Therapeutics, Inc.
Via
GlobeNewswire
Around $60 Million Bet On DICE Therapeutics? 3 Stocks Insiders Are Buying
October 20, 2022
Although US stocks closed lower on Wednesday, there were a few notable insider trades.
Via
Benzinga
Jim Cramer Says People Are Betting Against Stock Up 84% This Year: It Could Be An 'Up Big, Down Big Situation'
October 18, 2022
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he can’t recommend Dice Therapeutics Inc (NASDAQ: DICE) as the company is "losing money hand over fist."
Via
Benzinga
DICE Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
October 17, 2022
From
DICE Therapeutics, Inc.
Via
GlobeNewswire
Bear Market Hits New Lows, But Stocks Rebound After Hot CPI Inflation Report: Weekly Review
October 14, 2022
The major indexes tumbled to bear market lows after a hot CPI inflation report, but then roared back.
Via
Investor's Business Daily
DICE Announces Pricing of Upsized Public Offering of Common Stock
October 12, 2022
From
DICE Therapeutics, Inc.
Via
GlobeNewswire
Why Laser Photonics Shares Jumped By Around 44%; Here Are 72 Biggest Movers From Yesterday
October 12, 2022
Gainers FedNat Holding Company (NASDAQ: FNHC) shares climbed 107.7% to close at $0.3395 on Tuesday.
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.